FDA approves thrombopoiesis-stimulating agent.
Thompson
Cheryl A
CA
D002352:Carrier Proteins / Q000627:therapeutic use*; D002908:Chronic Disease; D017277:Drug Approval; D004351:Drug Resistance; D006801:Humans; D007279:Injections, Subcutaneous; D010976:Platelet Count; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000097:blood / Q000188:drug therapy*; D011961:Receptors, Fc / Q000627:therapeutic use*; D053628:Receptors, Thrombopoietin / Q000819:agonists*; D011993:Recombinant Fusion Proteins; D034061:Thrombopoiesis / Q000187:drug effects*; D013926:Thrombopoietin; D014481:United States; D014486:United States Food and Drug Administration
D002352:Carrier Proteins; D011961:Receptors, Fc; D053628:Receptors, Thrombopoietin; D011993:Recombinant Fusion Proteins; D013926:Thrombopoietin; C488777:romiplostim